These experiments indicate that interventions to reduce NOX4 or to increase CCR2/CCL2 turnover may attenuate ethanol mediated oxidative stress in HSC at early stages, that later on may result in decreased liver fibrosis. This evidence concerns the gene NOX4 and Hepatic fibrosis.